• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human spreading factor: synthesis and response by HepG2 hepatoma cells in culture.

作者信息

Barnes D W, Reing J

出版信息

J Cell Physiol. 1985 Nov;125(2):207-14. doi: 10.1002/jcp.1041250206.

DOI:10.1002/jcp.1041250206
PMID:2997238
Abstract

Human serum spreading factor (SF) is a cell adhesion and spreading-promoting glycoprotein purified from serum or plasma that mediates effects in a wide variety of animal cell culture systems. HepG2 human hepatoma cells were found to synthesize and secrete SF into culture medium. Quantitative immunoassay of the protein indicated a concentration of about 1 microgram/ml in 48 hr-conditioned medium from confluent cultures. Although fibronectin also was synthesized and secreted into the culture medium, HepG2 cell spreading was observed in response to human serum SF, but not in response to human plasma fibronectin. Immunoprecipitation of SF from culture medium of cells metabolically-labeled with leucine, fucose or glucosamine identified a single form of the molecule of approximately 70,000 daltons. Treatment of cultures with tunicamycin inhibited incorporation of fucose and glucosamine into immunoprecipitated SF, but did not prevent synthesis and secretion of the protein. Electrophoretic analysis and cell spreading assays showed that SF secreted by tunicamycin-treated HepG2 cells was of molecular weight (mw) approximately 60,000, and was biologically active.

摘要

相似文献

1
Human spreading factor: synthesis and response by HepG2 hepatoma cells in culture.
J Cell Physiol. 1985 Nov;125(2):207-14. doi: 10.1002/jcp.1041250206.
2
Fibronectin synthesized by a human hepatoma cell line.由人肝癌细胞系合成的纤连蛋白。
Cancer Res. 1984 Jul;44(7):3022-8.
3
Spreading of human fibroblasts in serum-free medium: inhibition by dithiothreitol and the effect of cold insoluble globulin (plasma fibronectin).人成纤维细胞在无血清培养基中的铺展:二硫苏糖醇的抑制作用及冷不溶性球蛋白(血浆纤连蛋白)的影响
J Cell Physiol. 1980 Sep;104(3):321-34. doi: 10.1002/jcp.1041040306.
4
Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen, and an autocrine motility factor-like substance.人恶性间皮瘤细胞的趋化性和趋触性:纤连蛋白、层粘连蛋白、IV型胶原及一种自分泌运动因子样物质的作用
Cancer Res. 1993 Sep 15;53(18):4376-82.
5
Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.肿瘤抑制因子癌胚抗原相关细胞粘附分子1增强人肝癌HepG2细胞的非锚定依赖性生长。
Life Sci. 2007 Jul 4;81(4):336-45. doi: 10.1016/j.lfs.2007.06.002. Epub 2007 Jun 16.
6
Colon cancer cells adhesion and spreading on autocrine laminin-10 is mediated by multiple integrin receptors and modulated by EGF receptor stimulation.结肠癌细胞在自分泌层粘连蛋白-10上的黏附和扩散由多种整合素受体介导,并受表皮生长因子受体刺激的调节。
Exp Cell Res. 2000 Dec 15;261(2):360-71. doi: 10.1006/excr.2000.5065.
7
Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line.一种人肝癌细胞系对纤溶成分(包括α2 -抗纤溶酶)的合成与分泌。
J Lab Clin Med. 1983 Mar;101(3):372-84.
8
Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.非环状视黄酸对人肝癌细胞的生长抑制作用与p21(CIP1)的诱导及细胞周期蛋白D1表达的抑制相关。
Cancer Res. 2002 Jul 15;62(14):3997-4006.
9
The glycosylation characteristic of hepatoma-associated antigen HAb18G/CD147 in human hepatoma cells.人肝癌细胞中肝癌相关抗原HAb18G/CD147的糖基化特征
Int J Biochem Cell Biol. 2006;38(11):1939-45. doi: 10.1016/j.biocel.2006.05.008. Epub 2006 May 27.
10
Quantitation of spreading factor in human biologic fluids.人生物体液中扩散因子的定量分析。
J Lab Clin Med. 1984 May;103(5):783-91.

引用本文的文献

1
Vitronectins produced by human cirrhotic liver and CCl-treated rats differ in their glycosylation pattern and tissue remodeling activity.人肝硬化肝和 CCl4 处理大鼠产生的 vitronectins 在其糖基化模式和组织重塑活性方面存在差异。
FEBS Open Bio. 2019 Mar 18;9(4):755-768. doi: 10.1002/2211-5463.12616. eCollection 2019 Apr.
2
Screening of hepatocyte proteins binding with C‑terminally truncated surface antigen middle protein of hepatitis B virus (MHBst167) by a yeast two‑hybrid system.利用酵母双杂交系统筛选与乙型肝炎病毒C末端截短表面抗原中蛋白(MHBst167)结合的肝细胞蛋白
Mol Med Rep. 2014 Sep;10(3):1259-63. doi: 10.3892/mmr.2014.2356. Epub 2014 Jun 26.
3
Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes.
有证据表明,肝外细胞表达玻连蛋白mRNA的速率接近肝细胞的表达速率。
Histochem Cell Biol. 1996 Mar;105(3):195-201. doi: 10.1007/BF01462292.
4
Vitronectin secretion by hepatic and non-hepatic human cancer cells.人肝癌细胞和非肝癌细胞分泌玻连蛋白的情况。
In Vitro Cell Dev Biol Anim. 1993 May;29A(5):403-7. doi: 10.1007/BF02633989.
5
Evidence for an extra-cellular function for protein kinase A.蛋白激酶A细胞外功能的证据。
Mol Cell Biochem. 1993 Nov;127-128:283-91. doi: 10.1007/978-1-4615-2600-1_26.
6
Human and mouse S-protein mRNA detected in northern blot experiments and evidence for the gene encoding S-protein in mammals by Southern blot analysis.
Mol Cell Biochem. 1991 Feb 2;100(2):141-9. doi: 10.1007/BF00234163.
7
Detection of vitronectin mRNA in tissues and cells of the mouse.小鼠组织和细胞中玻连蛋白mRNA的检测。
Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9402-6. doi: 10.1073/pnas.88.21.9402.
8
Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.血清来源的玻连蛋白影响1型纤溶酶原激活物抑制剂的细胞周围分布。
J Cell Biol. 1990 Sep;111(3):1283-91. doi: 10.1083/jcb.111.3.1283.